Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Faron Pharmaceuticals
company
About
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- €2.50M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Oct 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€2.50M
Faron Pharmaceuticals has raised a total of
€2.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 11, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 11, 2020 | Grant | €2.50M | 1 |
European Innovation Council
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Faron Pharmaceuticals is funded by 1 investors.
European Innovation Council
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
